The relative efficiency of time‐to‐progression and continuous measures of cognition in presymptomatic Alzheimer's disease-Reference-Cited by-同舟云学术

The relative efficiency of time‐to‐progression and continuous measures of cognition in presymptomatic Alzheimer's disease

Published:2019-01 Issue:1 Volume:5 Page:308-318
ISSN:2352-8737
Container-title:Alzheimer's & Dementia: Translational Research & Clinical Interventions
language:en
Short-container-title:Alzheimer's & Dementia: Translational Research & Clinical Interventions

Author:

Li Dan¹,Iddi Samuel¹²,Aisen Paul S.¹,Thompson Wesley K.³,Donohue Michael C.¹,

Affiliation:

1. Alzheimer's Therapeutic Research Institute, Keck School of Medicine, University of Southern CaliforniaSan DiegoCAUSA

2. Department of StatisticsUniversity of GhanaLegon‐AccraGhana

3. Department of PsychiatryUniversity of CaliforniaSan DiegoCAUSA

Funder

National Institute on Aging

Alzheimer's Disease Neuroimaging Initiative

National Institutes of Health

U.S. Department of Defense

National Institute of Biomedical Imaging and Bioengineering

Canadian Institutes of Health Research

ADNI

DOD

Department of Defense

Publisher

Wiley

Subject

Psychiatry and Mental health,Neurology (clinical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.trci.2019.04.004

Reference24 articles.

1. Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

2. The A4 Study: Stopping AD Before Symptoms Begin?

3. ClinicalTrials.gov.An efficacy and safety study of atabecestat in participants who are asymptomatic at risk for developing Alzheimer's dementia (EARLY) Tech. rep. National Library of Medicine (US) Bethesda MD (2015 Oct 6 ‐ 2019 Jan 21).https://clinicaltrials.gov/ct2/show/NCT02569398 Accessed January 2019

4. Rationale for selection of primary endpoints in the Alzheimer Prevention Initiative Generation study in cognitively healthy APOE4 homozygotes, Alzheimer's & Dementia;Caputo A.;J Alzheimer's Assoc,2017

5. The Preclinical Alzheimer Cognitive Composite

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The temporal event-based model: Learning event timelines in progressive diseases;Imaging Neuroscience;2023-08

2. Rationale for the selection of dual primary endpoints in prevention studies of cognitively unimpaired individuals at genetic risk for developing symptoms of Alzheimer’s disease;Alzheimer's Research & Therapy;2023-03-06

3. Machine learning based multi-modal prediction of future decline toward Alzheimer’s disease: An empirical study;PLOS ONE;2022-11-16

4. Reduced synaptic proteins and SNARE complexes in Down syndrome with Alzheimer's disease and the Dp16 mouse Down syndrome model: Impact of APP gene dose;Alzheimer's & Dementia;2022-11-12

5. Disentangling the relationship of subjective cognitive decline and depressive symptoms in the development of cognitive decline and dementia;Alzheimer's & Dementia;2022-10-11